GRP
SUPN icon

Global Retirement Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Global Retirement Partners’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.4K Buy
+1,385
New +$66.5K ﹤0.01% 2352
2025
Q4 		$69.8K Buy
1,404
+1,182
+532% +$57.5K ﹤0.01% 2142
2025
Q3 		$10.6K Sell
222
-47
-17% -$1.89K ﹤0.01% 2678
2025
Q2 		$8.48K Buy
+269
New +$8.62K ﹤0.01% 2683
2024
Q4 		$2.39K Sell
66
-20
-23% -$704 ﹤0.01% 3002
2024
Q3 		$2.68K Hold
86
– – ﹤0.01% 2836
2024
Q2 		$2.3K Buy
86
+67
+353% +$1.94K ﹤0.01% 2918
2024
Q1 		$648 Hold
19
– – ﹤0.01% 3075
2023
Q4 		$541 Buy
+19
New +$504 ﹤0.01% 3061
2019
Q4 		– Sell
-500
Closed -$14K – 1696
2019
Q3 		$14K Hold
500
– – ﹤0.01% 1036
2019
Q2 		$17K Buy
+500
New +$17.1K ﹤0.01% 972

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Global Retirement Partners's SUPN Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 1,385 shares worth $64.4K. The stake represents ﹤0.01% of the portfolio and ranks #2352 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in SUPN as recently as Q4 2025.

Global Retirement Partners first reported a position in SUPN in Q2 2019 and has held it in 11 quarters since. The position peaked at $69.8K in Q4 2025. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Global Retirement Partners held 1,385 shares of Supernus Pharmaceuticals worth $64.4K as of Q2 2026.
  • Supernus Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2352 holding.
  • Global Retirement Partners first reported a position in Supernus Pharmaceuticals in Q2 2019 and has held it in 11 quarters since.
  • Global Retirement Partners's Supernus Pharmaceuticals position peaked at $69.8K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.